The following is a summary of “Off-label use of biologics in urticarial vasculitis: a European retrospective cohort study,” published in the January 2025 issue of Rheumatology by Maisonobe et al.
They're different from one type of vasculitis to another. So let's say, take for example, age can be a risk factor because there are some certain vasculitis that affect certain age type.
So a treatment plan, depending on which vasculitis you have. And most of the time these vasculitis are chronic, as we said, and they last for a long time. So, and then within, you know ...
Behçet's disease (BD) is a systemic large-vessel vasculitis characterized by a wide clinical spectrum including recurrent oral and genital ulcerations, uveitis, and vascular, neurological ...
The following is a summary of “Efficacy and safety of first-line targeted synthetic DMARDs in rheumatoid arthritis patients with chronic kidney disease,” published in the January 2025 issue of ...